Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial
· financialpost.com
The shipment of naturally derived psilocybin, comprising both biomass and 5mg capsules, supports a planned Phase 2 clinical trial in the United Kingdom and was comp…
Article content
This press release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws, includ...